MS patients in England offered 10-minute jab in place of infusions

A CT scan of the head of a young woman who has multiple sclerosis. The condition involves damage to myelin, an insulating layer around nerves including those in the brain. Photograph: imageBroker/Rex/Shutterstock

Thousands of people with multiple sclerosis in England are to benefit from a 10-minute injection that cuts the time they need to spend in hospital by more than 90%.

At the moment, patients taking the drug ocrelizumab (Ocrevus) require twice-yearly intravenous infusions, which can take four or five hours or more to administer every time they are in hospital.